Literature DB >> 12951033

Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells.

Oleg Zhirnov1, Hans-Dieter Klenk.   

Abstract

Replication of human influenza A/H3N2 and A/H1N1 viruses was studied in human CACO-2 cells, a continuous line of intestinal epithelial differentiated cells. Hemagglutinin (HA) was cleaved in these cells by an endogenous protease. Thus, infectious virus was produced that underwent multiple cycle replication and plaque formation in the absence of trypsin added to the media. Cleavage of de novo-synthesized HA occurred at a late stage of the exocytic pathway as indicated by pulse-chase labeling and by experiments employing endoglycosidase H and brefeldin A treatment. However, surface-labeling experiments employing biotinylation suggested that there is no cleavage at the plasma membrane. Unlike HA of serotypes H5 and H7 cleaved at multibasic cleavage sites by furin, the HAs with monobasic cleavage sites analyzed here were not cleaved in CACO-2 cells in the presence of aprotinin, a natural inhibitor of trypsinlike proteases. Growing CACO-2 cells were able to cleave HA of incoming virus, although influenza virus activating protease was not detected in culture medium. These observations indicate that the activating enzyme of CACO-2 cells is a trypsinlike protease functioning in the trans-Golgi network and presumably endosomes. In support of this concept immune staining with antibodies specific to human and bovine trypsin revealed the presence of a trypsinlike protease in CACO-2 cells. Unlike MDCK and CV-1 cells undergoing rapid apoptosis after influenza virus infection, CACO-2 cells showed no apoptosis but displayed cytopathic effects with necrotic signs significantly later after infection. It follows from these data that, depending on the cell type, influenza virus may kill cells either by apoptosis or by necrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951033     DOI: 10.1016/s0042-6822(03)00264-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells.

Authors:  Hui Zeng; Claudia Pappas; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

Review 2.  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Authors:  P Zarogoulidis; N Papanas; I Kioumis; E Chatzaki; E Maltezos; K Zarogoulidis
Journal:  Eur J Clin Pharmacol       Date:  2011-11-22       Impact factor: 2.953

3.  Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses.

Authors:  Samita S Andreansky; John Stambas; Paul G Thomas; Weidong Xie; Richard J Webby; Peter C Doherty
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.

Authors:  Stephanie Bertram; Ilona Glowacka; Paulina Blazejewska; Elizabeth Soilleux; Paul Allen; Simon Danisch; Imke Steffen; So-Young Choi; Youngwoo Park; Heike Schneider; Klaus Schughart; Stefan Pöhlmann
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

5.  TMPRSS2 is an activating protease for respiratory parainfluenza viruses.

Authors:  Masako Abe; Maino Tahara; Kouji Sakai; Hiromi Yamaguchi; Kazuhiko Kanou; Kazuya Shirato; Miyuki Kawase; Masahiro Noda; Hirokazu Kimura; Shutoku Matsuyama; Hideo Fukuhara; Katsumi Mizuta; Katsumi Maenaka; Yasushi Ami; Mariko Esumi; Atsushi Kato; Makoto Takeda
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

6.  Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.

Authors:  Samantha B Kasloff; Matteo S Pizzuto; Micol Silic-Benussi; Silvia Pavone; Vincenzo Ciminale; Ilaria Capua
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  Long-term respiratory follow-up of H1N1 infection.

Authors:  Paul Zarogoulidis; George Kouliatsis; Nikolaos Papanas; Dionysis Spyratos; Theodoros C Constantinidis; Ioannis Kouroumichakis; Paschalis Steiropoulos; Maria Mabroudi; Dimitris Matthaios; Theodora Kerenidi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis; Efstratios Maltezos
Journal:  Virol J       Date:  2011-06-25       Impact factor: 4.099

8.  Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.

Authors:  Yiu-Wing Kam; Yuushi Okumura; Hiroshi Kido; Lisa F P Ng; Roberto Bruzzone; Ralf Altmeyer
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

9.  Sulfatide regulates caspase-3-independent apoptosis of influenza A virus through viral PB1-F2 protein.

Authors:  Tadanobu Takahashi; Masahiro Takaguchi; Tatsuya Kawakami; Takashi Suzuki
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

10.  Comparison of different cell substrates on the measurement of human influenza virus neutralizing antibodies.

Authors:  Weiguo Zhai; Dan Ning Zhang; Cecilia Mai; Justin Choy; Gary Jian; Kuldip Sra; Mark S Galinski
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.